206 Results

People

  1. Moore
    Moore
  2. Kolesnick
    Kolesnick
  3. Marino
    Marino
  4. Old
    Old
  5. Blobel
    Blobel
  6. Houghton
    Houghton
  7. DeMatteo
    DeMatteo
  8. Fuks
    Fuks
  9. Ritter
    Ritter
  10. Gnjatic
    Gnjatic

Groups

  1. Sloan Kettering Institute Faculty (72)
  2. Department of Medicine (66)
  3. GSK Faculty (55)
  4. Division of Subspecialty Medicine (31)
  5. Molecular Pharmacology and Chemistry Program Faculty (28)
  6. Hematologic Malignancies, Division of (22)
  7. Solid Tumor Oncology Division (22)
  8. Cell Biology Program Faculty (20)
  9. Immunology Program Faculty (19)
  10. Surgery (19)
  1. "tumor necrosis factor alpha"
Formats
  1. Journal Article (203)
  2. Conference Paper (3)
Groups
  1. Sloan Kettering Institute Faculty (72)
  2. Department of Medicine (66)
  3. GSK Faculty (55)
  4. Division of Subspecialty Medicine (31)
  5. Molecular Pharmacology and Chemistry Program Faculty (28)
  6. Hematologic Malignancies, Division of (22)

More Groups

People
  1. Malcolm Moore (20)
  2. Richard Kolesnick (18)
  3. Lloyd Old (12)
  4. Michael Marino (12)
  5. Carl Blobel (10)
  6. Alan Houghton (7)

More People

Years
  1. 2021 (1)
  2. 2016 (2)
  3. 2015 (14)
  4. 2014 (7)
  5. 2013 (4)
  6. 2012 (10)

More Years

Publications
  1. Journal of Biological Chemistry (15)
  2. Journal of Immunology (13)
  3. Proceedings of the National Academy of Sciences of the United States of America (11)
  4. Cancer Research (7)
  5. Blood (5)
  6. Cell (5)

More Publications

Publishers
  1. Elsevier Inc. (19)
  2. American Society for Biochemistry and Molecular Biology (15)
  3. American Association for Cancer Research (14)
  4. The American Association of Immunologists, Inc (13)
  5. National Academy of Sciences (11)
  6. John Wiley & Sons (10)

More Publishers

Results (206)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Advances in the genetics of sarcoidosis
    Journal Article

    Smith, G.; Brownell, I.; Sanchez, M.; Prystowsky, S.
    Clinical Genetics (2008)

    Fulltext@MSK | Save
  • Recognition of naturally processed and ovarian cancer reactive CD8 + T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1
    Journal Article

    Matsuzaki, J.; Qian, F.; Luescher, I.; Lele, S.; Ritter, G.; Shrikant, P. A.; Gnjatic, S.; Old, L. J.; Odunsi, K.
    Cancer Immunology, Immunotherapy (2008)

    Fulltext@MSK | Save
  • Acid sphingomyelinase involvement in tumor necrosis factor α-regulated vascular and steroid disruption during luteolysis in vivo
    Journal Article

    Henkes, L. E.; Sullivan, B. T.; Lynch, M. P.; Kolesnick, R.; Arsenault, D.; Puder, M.; Davis, J. S.; Rueda, B. R.
    Proceedings of the National Academy of Sciences of the United States of America (2008)

    Fulltext@MSK | Save
  • Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth
    Journal Article

    Gounaris, E.; Tung, C. H.; Restaino, C.; Maehr, R.; Kohler, R.; Joyce, J. A.; Plough, H. L.; Barrett, T. A.; Weissleder, R.; Khazaie, K.
    PLoS ONE (2008)

    Fulltext@MSK | Save
  • A phase-I trial of the epidermal growth factor receptor directed bispecific antibody MDX-447 without and with recombinant human granulocyte-colony stimulating factor in patients with advanced solid tumors
    Journal Article

    Fury, M. G.; Lipton, A.; Smith, K. M.; Winston, C. B.; Pfister, D. G.
    Cancer Immunology, Immunotherapy (2008)

    Fulltext@MSK | Save
  • Clinical, immunological and histological aspects of an uncommon type II reaction in patients with lepromatous leprosy
    Journal Article

    Esquenazi, D.; Moreira, A. L.; Miranda, A.; Nery, J. A. C.; Alvarenga, F. F.; Sarno, E. N.; Pereira, G. M. B.
    Clinical and Experimental Dermatology (2008)

    Fulltext@MSK | Save
  • History of regional chemotherapy for cancer of the extremities
    Journal Article

    Ariyan, C. E.; Brady, M. S.
    International Journal of Hyperthermia (2008)

    Fulltext@MSK | Save
  • IFN-γ and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease
    Journal Article

    Ramirez-Montagut, T.; Chow, A.; Kochman, A. A.; Smith, O. M.; Suh, D.; Sindhi, H.; Lu, S.; Borsotti, C.; Grubin, J.; Patel, N.; more...
    Journal of Immunology (2007)

    Fulltext@MSK | Save
  • Treatment of vitiligo vulgaris with narrow-band UVB and oral polypodium leucotomos extract: A randomized double-blind placebo-controlled study
    Journal Article

    Middelkamp-Hup, M. A.; Bos, J. D.; Rius-Diaz, F.; Gonzalez, S.; Westerhof, W.
    Journal of the European Academy of Dermatology and Venereology (2007)

    Fulltext@MSK | Save
  • Murine liver plasmacytoid dendritic cells become potent immunostimulatory cells after Flt-3 ligand expansion
    Journal Article

    Kingham, T. P.; Chaudhry, U. I.; Plitas, G.; Katz, S. C.; Raab, J.; DeMatteo, R. P.
    Hepatology (2007)

    Fulltext@MSK | Save